Substantial Effects of Luseogliflozin Revealed by Analyzing Responses to Postprandial Hyperglycemia: Post Hoc Subanalyses of a Randomized Controlled Study

INTRODUCTION: In our previous study investigating effects of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, on 24-h glycemic variability by continuous glucose monitoring (CGM), luseogliflozin elicited parallel downward shifts in fasting and postprandial glucose levels. However, further...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Adv Ther
Hauptverfasser: Samukawa, Yoshishige, Omiya, Hirohisa, Watase, Hirotaka, Nozaki, Kazunari, Sakai, Soichi, Nishimura, Rimei
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Healthcare 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939154/
https://ncbi.nlm.nih.gov/pubmed/27255763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0350-5
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge